new data findings/day
patient tests analyzed
Access over 40 genomic, clinical and pharmaceutical databases updated weekly by hundreds of expert curators.
Enrich your NGS analysis and interpretations with cutting-edge bioinformatics software solutions trusted by thousands worldwide.
Make improvements in life possible by partnering with one bioinformatics software provider empowering you from Sample to Insight.
More mutations, better annotations, confident classifications HGMD Professional 2022.2 is now avail...
Part 1: Overcoming NGS data analysis challenges of high-throughput sequencing Today clinical diagno...
How to easily create, manage and share adverse outcome pathways to accelerate drug discovery program...
Do you spend hours cleaning up and integrating ‘omics data, yet still feel like you are drowning i...
COSMIC v96 adds new oncogene that may be beneficial to diagnose HNSCC Head and neck cancers are a h...
New Content Release: HGMD Professional 2022.2
The Scale-up Series: How clinical diagnostic labs can ﬂexibly scale NGS data analysis
Take the legwork out of drug toxicity screening
Avoid the 'omics data odyssey with a helping hand
Know your biomarkers: How PRKD1 is linked to head and neck squamous cell carcinoma (HNSCC)
Targeted NGS panels and optimized analysis and interpretation bioinformatics software tools.
Discovery Bioinformatics Services is a reliable and convenient way to extend your in-house resources with expertise and perfectly tailored bioinformatics software and services that ensure high-quality results.
Enabling pharma companies to develop biomarker diagnostics and targeted therapies using real-world insights from oncology patient genomic data.
Helping clinical testing laboratories leverage the benefits of automation and expert support to improve test turnaround times, enhance clinical reporting capabilities and scale for future growth.
Join us at an event or attend a webinar to learn how our products, solutions and services are empowering customers around the world to unlock valuable molecular insights.
Çukurova University in Adana, Turkey, analyzes the ancient origins of rare genetic diseases
Scientists at the University of Washington develop new Ebola model and find clues to genetics of host resistance
Mount Sinai identifies a novel prognostic biomarker associated with treatement response in ovarian cancer patients